XML 42 R33.htm IDEA: XBRL DOCUMENT v3.23.2
Restatement - Restatements (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Jan. 01, 2022
Dec. 31, 2021
Current assets:                  
Cash and cash equivalents $ 238,937   $ 215,537   $ 238,937 $ 215,537 $ 189,082    
Accounts receivable, net of allowances of $4,508 13,495   12,993   13,495 12,993 13,177    
Allowance for credit loss 5,734 $ 4,870 4,508 $ 3,633 5,734 4,508 4,730   $ 4,060
Prepaid expenses and other current assets 13,308   13,860   13,308 13,860 16,699    
Total current assets 288,462   242,390   288,462 242,390 241,680    
Property and equipment, net 38,894   49,342   38,894 49,342 30,823    
Goodwill 63,265   59,933   63,265 59,933 63,229    
Intangible assets, net 16,317   14,570   16,317 14,570 18,900    
Operating lease right-of-use assets 9,875   6,961   9,875 6,961 11,148 $ 5,700  
Deferred income taxes 21,831   29,749   21,831 29,749 29,380    
Available-for-sale debt securities 1,004   1,182   1,004 1,182 995    
Other assets 8,989   13,312   8,989 13,312 9,240    
Total assets 448,637   417,439   448,637 417,439 405,395    
Current liabilities:                  
Accounts payable 33,307   18,404   33,307 18,404 25,312    
Accrued expenses and other current liabilities 52,349   54,585   52,349 54,585 57,373    
Deferred revenue 179,432   163,140   179,432 163,140 164,200    
Operating lease liabilities 2,405   1,542   2,405 1,542 2,317    
Total current liabilities 267,493   237,671   267,493 237,671 249,202    
Operating lease liabilities, non-current 7,800   4,842   7,800 4,842 8,958    
Deferred revenue 711   1,137   711 1,137 892    
Other liabilities 4,284   2,841   4,284 2,841 3,968    
Total liabilities 280,288   246,491   280,288 246,491 263,020    
Stockholders’ equity:                  
Preferred stock, $0.001 par value; 100,000 shares authorized at June 30, 2023 and December 31, 2022, none issued or outstanding at June 30, 2023 and December 31, 2022 $ 0   $ 0   $ 0 $ 0 $ 0    
Preferred stock par value (in dollars per share) $ 0.001   $ 0.001   $ 0.001 $ 0.001 $ 0.001    
Preferred stock shares authorized (in shares) 100,000,000   100,000   100,000,000 100,000 100,000,000    
Preferred stock shares issued (in shares) 0   0   0 0 0    
Preferred stock shares outstanding (in shares) 0   0   0 0 0    
Common stock, $0.001 par value; 1,000,000 shares authorized; 191,657 shares and 190,822 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively $ 191   $ 196   $ 191 $ 196 $ 190    
Common stock par value (in dollars per share) $ 0.001   $ 0.001   $ 0.001 $ 0.001 $ 0.001    
Common stock shares authorized (in shares) 1,000,000,000   1,000,000   1,000,000,000 1,000,000 1,000,000,000    
Common stock shares issued (in shares) 191,657,000   196,079   191,657,000 196,079 190,822,000    
Common stock shares outstanding (in shares) 191,657,000   196,079   191,657,000 196,079 190,822,000    
Additional paid-in capital $ 1,070,461   $ 994,558   $ 1,070,461 $ 994,558 $ 1,032,550    
Accumulated deficit (902,633)   (825,660)   (902,633) (825,660) (891,862)    
Accumulated other comprehensive income 330   1,854   330 1,854 1,497    
Total stockholders’ equity 168,349 150,017 170,948 194,707 168,349 170,948 142,375   197,551
Total liabilities and stockholders’ equity 448,637   417,439   448,637 417,439 405,395    
Income Statement [Abstract]                  
Revenue 168,854   162,649   334,790 318,076      
Cost of revenue 63,748   57,151   124,143 113,333      
Gross profit 105,106   105,498   210,647 204,743      
Operating expenses:                  
Sales and marketing 53,525   71,721   113,675 148,595      
Technology and development 19,900   16,197   39,583 34,156      
General and administrative 26,936   28,969   53,440 58,457      
Total operating expenses 100,361   116,887   206,698 241,208      
Loss from operations 4,745   (11,389)   3,949 (36,465)      
Interest income (expense), net 2,153   29   3,734 (24)      
Other expense, net 624   (2,022)   1,318 (3,566)      
Loss before income taxes 7,522   (13,382)   9,001 (40,055)      
Provision for (benefit from) income taxes 6,127   (639)   9,964 (1,559)      
Net loss $ 1,395 (2,358) $ (12,743) (25,753) $ (963) $ (38,496)      
Net loss per attributable to common stockholders - basic (in dollars per share) $ 0.01   $ (0.06)   $ (0.01) $ (0.19)      
Net loss per attributable to common stockholders - diluted (in dollars per share) $ 0.01   $ (0.06)   $ (0.01) $ (0.19)      
Weighted-average shares used to compute net income (loss) per share attributable to common stockholders—basic (in shares) 191,342,000   197,819,000   191,318,000 198,040,000      
Weighted-average shares used to compute net income (loss) per share attributable to common stockholders—diluted (in shares) 194,826,000   197,819,000   191,318,000 198,040,000      
Statement of Other Comprehensive Income [Abstract]                  
Net loss $ 1,395 (2,358) $ (12,743) (25,753) $ (963) $ (38,496)      
Other comprehensive income (loss) (536) (631) 2,209 1,440 (1,167) 3,649      
Total comprehensive loss 859   (10,534)   (2,130) (34,847)      
Statement of Stockholders' Equity [Abstract]                  
Beginning balance 150,017 142,375 194,707 197,551 142,375 197,551      
Cumulative adjustments to net loss 859   (10,534)   (2,130) (34,847)      
Ending balance 168,349 150,017 170,948 194,707 168,349 170,948      
Cash flows from operating activities                  
Net income (loss) 1,395 (2,358) (12,743) (25,753) (963) (38,496)      
Adjustments to reconcile net loss to net cash provided by operating activities:                  
Depreciation and amortization 5,837   5,539   11,406 10,933      
Amortization of right-of-use assets         1,336 852      
Amortization of debt issuance costs         112 112      
Impairment of other equity security         0 170      
Stock-based compensation         35,423 44,712      
Deferred income taxes         7,614 (2,109)      
Change in fair value of contingent consideration         (695) (150)      
Unrealized foreign exchange (gain) loss (500)   2,000   (1,104) 3,405      
Other         (1) (1)      
Changes in operating assets and liabilities:                  
Accounts receivable         (316) (2,357)      
Prepaid expenses and other current assets         3,407 (417)      
Other assets         4 (338)      
Accounts payable         8,319 (13,553)      
Accrued expenses and other liabilities         (4,082) 6,921      
Operating lease liabilities         (1,132) (1,642)      
Income tax payable         8 15      
Deferred revenue         15,037 16,700      
Net cash provided by operating activities         74,373 24,757      
Cash flows from investing activities                  
Proceeds from acquisition working capital adjustment         0 307      
Purchase of property and equipment         (15,227) (10,379)      
Net cash used in investing activities         (15,227) (10,072)      
Cash flows from financing activities                  
Payment of contingent consideration         0 (600)      
Repurchase and retirement of common stock         (9,809) (39,155)      
Shares surrendered for settlement of minimum statutory tax withholding         (2,469) (30)      
Proceeds from issuance of stock under employee stock plans         2,973 1,487      
Net cash used in financing activities         (9,323) (38,298)      
Effect of exchange rate changes on cash and cash equivalents         32 (147)      
Net increase (decrease) in cash and cash equivalents         49,855 (23,760)      
Cash and cash equivalents, at beginning of the period   189,082   239,297 189,082 239,297      
Cash and cash equivalents, at end of the period 238,937   215,537   238,937 215,537      
Common Stock                  
Stockholders’ equity:                  
Total stockholders’ equity $ 191 $ 190 $ 196 $ 198 $ 191 $ 196 190   198
Statement of Stockholders' Equity [Abstract]                  
Beginning balance, shares 191,244,000 190,822,000 198,599,000 198,084,000 190,822,000 198,084,000      
Beginning balance $ 190 $ 190 $ 198 $ 198 $ 190 $ 198      
Ending balance, shares 191,657,000 191,244,000 196,079,000 198,599,000 191,657,000 196,079,000      
Ending balance $ 191 $ 190 $ 196 $ 198 $ 191 $ 196      
Additional Paid-In Capital                  
Stockholders’ equity:                  
Total stockholders’ equity 1,070,461 1,049,948 994,558 969,731 1,070,461 994,558 1,032,550   947,160
Statement of Stockholders' Equity [Abstract]                  
Beginning balance 1,049,948 1,032,550 969,731 947,160 1,032,550 947,160      
Ending balance 1,070,461 1,049,948 994,558 969,731 1,070,461 994,558      
Accumulated Deficit                  
Stockholders’ equity:                  
Total stockholders’ equity (902,633) (900,987) (825,660) (774,867) (902,633) (825,660) (891,862)   (748,012)
Operating expenses:                  
Net loss 1,395 (2,358) (12,743) (25,753)          
Statement of Other Comprehensive Income [Abstract]                  
Net loss 1,395 (2,358) (12,743) (25,753)          
Statement of Stockholders' Equity [Abstract]                  
Beginning balance (900,987) (891,862) (774,867) (748,012) (891,862) (748,012)      
Ending balance (902,633) (900,987) (825,660) (774,867) (902,633) (825,660)      
Cash flows from operating activities                  
Net income (loss) 1,395 (2,358) (12,743) (25,753)          
Accumulated Other Comprehensive (Loss) Income                  
Stockholders’ equity:                  
Accumulated other comprehensive income 330 866 1,854 (355) 330 1,854 1,497   (1,795)
Total stockholders’ equity 330 866 1,854 (355) 330 1,854 $ 1,497   $ (1,795)
Statement of Other Comprehensive Income [Abstract]                  
Other comprehensive income (loss) (536) (631) 2,209 1,440          
Statement of Stockholders' Equity [Abstract]                  
Beginning balance 866 1,497 (355) (1,795) 1,497 (1,795)      
Ending balance $ 330 $ 866 1,854 (355) $ 330 1,854      
As Reported                  
Current assets:                  
Cash and cash equivalents     215,537     215,537      
Accounts receivable, net of allowances of $4,508     12,993     12,993      
Allowance for credit loss     4,508     4,508      
Prepaid expenses and other current assets     13,860     13,860      
Total current assets     242,390     242,390      
Property and equipment, net     49,342     49,342      
Goodwill     59,933     59,933      
Intangible assets, net     14,570     14,570      
Operating lease right-of-use assets     6,961     6,961      
Deferred income taxes     25,685     25,685      
Available-for-sale debt securities     1,182     1,182      
Other assets     13,319     13,319      
Total assets     413,382     413,382      
Current liabilities:                  
Accounts payable     18,404     18,404      
Accrued expenses and other current liabilities     55,820     55,820      
Deferred revenue     163,140     163,140      
Operating lease liabilities     1,542     1,542      
Total current liabilities     238,906     238,906      
Operating lease liabilities, non-current     4,842     4,842      
Deferred revenue     1,137     1,137      
Other liabilities     2,841     2,841      
Total liabilities     247,726     247,726      
Stockholders’ equity:                  
Preferred stock, $0.001 par value; 100,000 shares authorized at June 30, 2023 and December 31, 2022, none issued or outstanding at June 30, 2023 and December 31, 2022     0     0      
Common stock, $0.001 par value; 1,000,000 shares authorized; 191,657 shares and 190,822 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively     196     196      
Additional paid-in capital     994,558     994,558      
Accumulated deficit     (830,952)     (830,952)      
Accumulated other comprehensive income     1,854     1,854      
Total stockholders’ equity     165,656     165,656      
Total liabilities and stockholders’ equity     413,382     413,382      
Income Statement [Abstract]                  
Revenue     163,867     318,076      
Cost of revenue     57,393     113,333      
Gross profit     106,474     204,743      
Operating expenses:                  
Sales and marketing     72,945     149,819      
Technology and development     16,197     34,156      
General and administrative     28,969     58,457      
Total operating expenses     118,111     242,432      
Loss from operations     (11,637)     (37,689)      
Interest income (expense), net     29     (24)      
Other expense, net     (2,022)     (3,566)      
Loss before income taxes     (13,630)     (41,279)      
Provision for (benefit from) income taxes     (451)     2,509      
Net loss     $ (13,179)     $ (43,788)      
Net loss per attributable to common stockholders - basic (in dollars per share)     $ (0.07)     $ (0.22)      
Net loss per attributable to common stockholders - diluted (in dollars per share)     $ (0.07)     $ (0.22)      
Weighted-average shares used to compute net income (loss) per share attributable to common stockholders—basic (in shares)     197,819,000     198,040,000      
Weighted-average shares used to compute net income (loss) per share attributable to common stockholders—diluted (in shares)     197,819,000     198,040,000      
Statement of Other Comprehensive Income [Abstract]                  
Net loss     $ (13,179)     $ (43,788)      
Other comprehensive income (loss)     2,209     3,649      
Total comprehensive loss     (10,970)     (40,139)      
Statement of Stockholders' Equity [Abstract]                  
Beginning balance                  
Cumulative adjustments to net loss     (10,970)     (40,139)      
Ending balance     165,656     165,656      
Cash flows from operating activities                  
Net income (loss)     (13,179)     (43,788)      
Adjustments to reconcile net loss to net cash provided by operating activities:                  
Depreciation and amortization           10,933      
Amortization of right-of-use assets           852      
Amortization of debt issuance costs           112      
Impairment of other equity security           170      
Stock-based compensation           44,712      
Deferred income taxes           1,955      
Change in fair value of contingent consideration           (150)      
Unrealized foreign exchange (gain) loss           3,405      
Other           (1)      
Changes in operating assets and liabilities:                  
Accounts receivable           (2,357)      
Prepaid expenses and other current assets           (417)      
Other assets           (345)      
Accounts payable           (13,553)      
Accrued expenses and other liabilities           8,156      
Operating lease liabilities           (1,642)      
Income tax payable           15      
Deferred revenue           16,700      
Net cash provided by operating activities           24,757      
Cash flows from investing activities                  
Proceeds from acquisition working capital adjustment           307      
Purchase of property and equipment           (10,379)      
Net cash used in investing activities           (10,072)      
Cash flows from financing activities                  
Payment of contingent consideration           (600)      
Repurchase and retirement of common stock           (39,155)      
Shares surrendered for settlement of minimum statutory tax withholding           (30)      
Proceeds from issuance of stock under employee stock plans           1,487      
Net cash used in financing activities           (38,298)      
Effect of exchange rate changes on cash and cash equivalents           (147)      
Net increase (decrease) in cash and cash equivalents           (23,760)      
Cash and cash equivalents, at beginning of the period       239,297   239,297      
Cash and cash equivalents, at end of the period     215,537     215,537      
As Reported | Common Stock                  
Stockholders’ equity:                  
Total stockholders’ equity     $ 196     $ 196      
Statement of Stockholders' Equity [Abstract]                  
Beginning balance, shares                  
Beginning balance                  
Ending balance, shares     196,079,000     196,079,000      
Ending balance     $ 196     $ 196      
As Reported | Additional Paid-In Capital                  
Stockholders’ equity:                  
Total stockholders’ equity     994,558     994,558      
Statement of Stockholders' Equity [Abstract]                  
Beginning balance                  
Ending balance     994,558     994,558      
As Reported | Accumulated Deficit                  
Stockholders’ equity:                  
Total stockholders’ equity     (830,952)     (830,952)      
Statement of Stockholders' Equity [Abstract]                  
Beginning balance                  
Ending balance     (830,952)     (830,952)      
As Reported | Accumulated Other Comprehensive (Loss) Income                  
Stockholders’ equity:                  
Total stockholders’ equity     1,854     1,854      
Statement of Stockholders' Equity [Abstract]                  
Beginning balance                  
Ending balance     1,854     1,854      
Adjustments                  
Current assets:                  
Cash and cash equivalents     0     0      
Accounts receivable, net of allowances of $4,508     0     0      
Prepaid expenses and other current assets     0     0      
Total current assets     0     0      
Property and equipment, net     0     0      
Goodwill     0     0      
Intangible assets, net     0     0      
Operating lease right-of-use assets     0     0      
Deferred income taxes     4,064     4,064      
Available-for-sale debt securities     0     0      
Other assets     (7)     (7)      
Total assets     4,057     4,057      
Current liabilities:                  
Accounts payable     0     0      
Accrued expenses and other current liabilities     (1,235)     (1,235)      
Deferred revenue     0     0      
Operating lease liabilities     0     0      
Total current liabilities     (1,235)     (1,235)      
Operating lease liabilities, non-current     0     0      
Deferred revenue     0     0      
Other liabilities     0     0      
Total liabilities     (1,235)     (1,235)      
Stockholders’ equity:                  
Preferred stock, $0.001 par value; 100,000 shares authorized at June 30, 2023 and December 31, 2022, none issued or outstanding at June 30, 2023 and December 31, 2022     0     0      
Common stock, $0.001 par value; 1,000,000 shares authorized; 191,657 shares and 190,822 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively     0     0      
Additional paid-in capital     0     0      
Accumulated deficit     5,292     5,292      
Accumulated other comprehensive income     0     0      
Total stockholders’ equity     5,292     5,292      
Total liabilities and stockholders’ equity     4,057     4,057      
Income Statement [Abstract]                  
Revenue     (1,218)     0      
Cost of revenue     (242)     0      
Gross profit     (976)     0      
Operating expenses:                  
Sales and marketing     (1,224)     (1,224)      
Technology and development     0     0      
General and administrative     0     0      
Total operating expenses     (1,224)     (1,224)      
Loss from operations     248     1,224      
Interest income (expense), net     0     0      
Other expense, net     0     0      
Loss before income taxes     248     1,224      
Provision for (benefit from) income taxes     (188)     (4,068)      
Net loss     $ 436     $ 5,292      
Net loss per attributable to common stockholders - basic (in dollars per share)     $ 0     $ 0      
Net loss per attributable to common stockholders - diluted (in dollars per share)     $ 0     $ 0      
Weighted-average shares used to compute net income (loss) per share attributable to common stockholders—basic (in shares)     0     0      
Weighted-average shares used to compute net income (loss) per share attributable to common stockholders—diluted (in shares)     0     0      
Statement of Other Comprehensive Income [Abstract]                  
Net loss     $ 436     $ 5,292      
Other comprehensive income (loss)     0     0      
Total comprehensive loss     436     5,292      
Statement of Stockholders' Equity [Abstract]                  
Beginning balance                  
Cumulative adjustments to net loss     436     5,292      
Ending balance     5,292     5,292      
Cash flows from operating activities                  
Net income (loss)     436     5,292      
Adjustments to reconcile net loss to net cash provided by operating activities:                  
Depreciation and amortization           0      
Amortization of right-of-use assets           0      
Amortization of debt issuance costs           0      
Impairment of other equity security           0      
Stock-based compensation           0      
Deferred income taxes           (4,064)      
Change in fair value of contingent consideration           0      
Unrealized foreign exchange (gain) loss           0      
Other           0      
Changes in operating assets and liabilities:                  
Accounts receivable           0      
Prepaid expenses and other current assets           0      
Other assets           7      
Accounts payable           0      
Accrued expenses and other liabilities           (1,235)      
Operating lease liabilities           0      
Income tax payable           0      
Deferred revenue           0      
Net cash provided by operating activities           0      
Cash flows from investing activities                  
Proceeds from acquisition working capital adjustment           0      
Purchase of property and equipment           0      
Net cash used in investing activities           0      
Cash flows from financing activities                  
Payment of contingent consideration           0      
Repurchase and retirement of common stock           0      
Shares surrendered for settlement of minimum statutory tax withholding           0      
Proceeds from issuance of stock under employee stock plans           0      
Net cash used in financing activities           0      
Effect of exchange rate changes on cash and cash equivalents           0      
Net increase (decrease) in cash and cash equivalents           0      
Cash and cash equivalents, at beginning of the period       $ 0   0      
Cash and cash equivalents, at end of the period     $ 0     0      
Adjustments | Accumulated Deficit                  
Statement of Other Comprehensive Income [Abstract]                  
Total comprehensive loss           5,292      
Statement of Stockholders' Equity [Abstract]                  
Cumulative adjustments to net loss           $ 5,292